TAT and cancer: The same authors [91] also reported on the development of multiple functions integrated into one system, including the ability to entrap a combination of therapeutic entities with different physicochemical properties (i.e., small interfering RNAs, siRNA and DOX), passive and active cancer targeting mediated by the Tat sequence and RGD4C, respectively, cell membrane translocation and pH-triggered drug release.